MedTrace Logo

Treatment Strategies for Primarily Generalized Colorectal Cancer

NCT01056809 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 15

Last updated 2012-05-31

No results posted yet for this study

Summary

For patients with primarily generalized colorectal cancer two treatment strategies are compared to establish which strategy gives best overall survival.

The traditional strategy is to first resect the primary colorectal tumour and then treat the metastases with chemotherapy followed if possible by surgery.

The alternative strategy is to first treat the metastases with chemotherapy followed if possible by surgery and only resect the primary colorectal tumour if there is hope for cure or if symptoms develop that necessitates treatment.

Conditions

Interventions

PROCEDURE

Chemotherapy and surgery

Treatment not specified but in accordance with national guidelines

Sponsors & Collaborators

  • Medical Research Council of Southeast Sweden

    collaborator OTHER_GOV

  • Vrinnevi Hospital

    lead OTHER

Principal Investigators

  • Gunnar Arbman, MD, PhD · Department of Surgery in Östergötland

  • Per Sandström, MD, PhD · Department of Surgery in Östergötland

  • Hans Starkhammar, MD, PhD · Regional Oncologic Center, Linköping

  • Bengt Glimelius, Professor · University of Uppsala, The Karolinska University Hospital, Stockholm

  • Lars Lundell, Professor · The Karolinska University Hospital, Stockholm

  • Per-Olof Nyström, Professor · The Karolinska Universtiy Hospital, Stockholm

  • Ulf Gunnarsson, Professor · The Karolinska University hospital, Stockholm

  • Lars Påhlman, Professor · Uppsala University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-01-31
Primary Completion
2012-05-31
Completion
2012-05-31

Countries

  • Sweden

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01056809 on ClinicalTrials.gov